Sterile Injectables Market | Size | Share | Forecast 2018 to 2024

13/giu/2018 09:44:32 PBIGP Contatta l'autore

Questo comunicato è stato pubblicato più di 6 mesi fa. Le informazioni su questa pagina potrebbero non essere attendibili.


Sterile Injectables Market report offers Market Size, Dynamics, Regional Market Share, Top Key Players, Latest trends, Growth factors, Industry Stats, Historic Market, Business Intelligence, Business Research Reports, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024


Sterile Injectables advertise report gives a thorough point of view toward clean injectable over the globe with exceptional accentuation on key areas, for example, North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa (MEA). This provide details regarding the clean injectable market gives chronicled, ebb and flow, and future market sizes (US$ Mn) of medication atoms, tranquilize sorts, malady application, course of organization, end clients, and geographic districts. This report considers clean injectable market elements intricately to distinguish the ebb and flow patterns and drivers, future open doors and conceivable difficulties to the key partners working in the market. What's more, the clean injectable market report incorporates tranquilize pipeline examination, administrative situation, and rivalry investigation with clearly represented the opposition dashboard to survey the market rivalry. In addition, PBI broke down clean injectable market to better furnish customers with conceivable speculation openings over the locales (Regional Investment Hot-Spots) and market neglected necessities (Product Opportunities). Key partners of the clean injectable market report incorporate providers, producers, advertisers, policymakers occupied with assembling and supply of sterile injectables.


A sample of this report is available upon request @



Sterile Injectables Market:


The sterile injectable market estimated to be valued US$ 361 Bn in 2016 and poised to grow at CAGR 7.3%. The market for sterile injectable projected to reach US$ 552 Bn by 2023.


Do the burgeoning product pipelines and drug patent expiries have a positive impact on the market?


The rising shift of pharmaceutical and biotechnology firms towards the development of medications for chronic diseases such as cancer, diabetes, and cardiovascular and among others have created ample growth opportunities for players in the market. Moreover, biologic have become a larger part of product pipelines of several drug developers, which could affect market growth positively over the forecast period. For instance, there are around 2,500 injectable products are in the developmental stage. Moreover, rising product patent expiries of several blockbusters in recent times expected to propel market growth over the forecast period. For instance, in 2015, Teva Pharmaceutical Industries Ltd. lost the patent for its top-selling multiple sclerosis drug Copaxone.


How operational and installation cost effects the sterile injectable market?


Several industry experts noted that the cost of establishing sterile injectable plants is significantly higher viz-a-viz non-sterile manufacturing plants owing to stringent aseptic requirements and complex manufacturing process; this has led to the consolidation of the industry by backward and forward integration. Moreover, competition from low-cost manufacturers, value chain integration coupled with high entry barrier for new players in the sterile injectable market expect impact market growth negatively over the forecast period.


To view TOC of this report is available upon request @



North America accounts for larger market revenue share in global sterile injectable market


North America leads the global sterile injectable market in terms of revenue in 2016. Regions such as Asia Pacific and Europe presented better growth opportunities for the market players owing to conducive business policies and increased local production generic injectable. For instance, in 2013, Mylan Inc. completed the acquisition of the Agila injectables businesses from Strides Arcolab Limited.


Competition Assessment


Key players profiled in the global sterile injectable market include:

·         AbbVie Inc. (U.S)

·         Amgen Inc. (U.S)

·         AstraZeneca plc (U.K)

·         Baxter International Inc. (U.S)

·         Eli Lilly and Company (U.S)


·         GlaxoSmithKline plc. (U.K)

·         Johnson & Johnson Services, Inc. (U.S)

·         Merck & Co., Inc. (U.S)

·         Novo Nordisk A/S (Denmark)

·         Novartis AG (Switzerland)

·         Pfizer Inc. (U.S)

·         F. Hoffmann-La Roche AG (Switzerland)

·         Sanofi (France)

Market players are focusing on mergers and acquisitions to improve their market position in sterile injectable market. For instance, in 2016, Baxter International Inc. acquired Claris Injectables Limited, a wholly owned subsidiary of Claris Lifesciences Limited, for total consideration of approximately $625mn. In 2015 Pfizer Inc. acquired Hospira, Inc., world’s leading provider of injectable and infusion technologies.

Key Findings of the Report:


·         Sterile injectable market expanding at 7.3% CAGR over 2017 to 2013 to reach market value of US$ 552 Bn by 2023

·         Based on molecule type large molecules accounted for larger market share in 2016

·         Oncology segment expected to be most lucrative market in global sterile injectable market

·         Hospital pharmacies are prime channel for sterile drug distribution across the globe

·         Players focusing on expanding geographic presence to garner market opportunities in developing economies

Key Features of the Report:


·         The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)

·         The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies

·         The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market

·         The report tracks recent innovations, key developments and startup’s details that are actively working in the market

·         The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario

·         The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market


Need more information about this report @


Detailed Segmentation


By Molecule Type

·         Large Molecules

·         Small Molecules

Drug Type

·         Monoclonal Antibodies

·         Cytokines

·         Insulin

·         Peptide Hormones

·         Blood Factors

·         Vaccines

·         Immunoglobulins

·         Peptide Antibiotics

·         Others

Disease Indication

·         Cancer

·         Diabetes

·         Cardiovascular Diseases

·         Musculoskeletal

·         CNS

·         Infections

·         Others

Route of Administration

·         Intravenous (IV)

·         Intramuscular (IM)

·         Subcutaneous (SC)

·         Others


Distribution Channel

·         Hospital Pharmacies

·         Retail Pharmacies

·         Online Pharmacies



·         North America

o    U.S.

o    Canada

·         Europe

o    Germany

o    France

o    K

o    Italy

o    Spain

o    Russia

o    Poland

o    Rest of Europe

·         Asia-Pacific

o    Japan

o    China

o    India

o    Australia & New Zealand

o    ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)

o    South Korea

o    Rest of Asia-Pacific

·         Latin America

o    Brazil

o    Mexico

o    Argentina

o    Venezuela

o    Rest of Latin America

·         Middle East and Africa (MEA)

o    Gulf Cooperation Council (GCC) Countries

o    Israel

o    South Africa

o    Rest of MEA


Get access to full summary @


About Precision Business Insights


Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.


Contact to Precision Business Insights,


Kemp House,

152 – 160 City Road,

London EC1V 2NX




Toll Free (US): +1-866-598-1553

Website @


Image & Author Bio:


blog comments powered by Disqus è un servizio offerto da Factotum Srl